The weekly litigation news digest is live. Subscribe now

IP Verse

Methods And Formulations Which Allow The Modulation Of Immune Responses Related To The Administration Of A Biopharmaceutical Drug - EP3021833

The patent EP3021833 was granted to Hexal on Mar 30, 2022. The application was originally filed on Jul 21, 2014 under application number EP14744505A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3021833

HEXAL
Application Number
EP14744505A
Filing Date
Jul 21, 2014
Status
Patent Maintained As Amended
Feb 25, 2022
Publication Date
Mar 30, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MURPHYMar 26, 2019- -

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2012237547
INTERNATIONAL-SEARCH-REPORTWO2012089778
INTERNATIONAL-SEARCH-REPORTWO2013011076
OPPOSITIONWO2004016286
OPPOSITIONWO2012065072
OPPOSITIONWO2012089778

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents